EGFR and myeloid sarcoma: Based on these findings, our study aimed to investigate the expression profiles of the three lncRNAs (lnc-EGFR, SNHG1, and lincRNA-Cox2) in Egyptian patients with RRMS during active relapses and in remission in an attempt to assess their impact on MS activity and future progression.